Frontlight ResearchEarly access
Head and neck cancer trials in United States
391 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleTesting What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Where
- Albuquerque, Altoona, Anaheim, Ankeny, Ann Arbor, Antigo, Appleton, Asheboro, Atlanta, Baltimore, Basking Ridge, Beavercreek, Bellflower, Bemidji, Birmingham, Bismarck, Boston, Cape Girardeau, Centerville, Chapel Hill, Charleston, Chicago, City of Saint Peters, Clackamas, Cleveland, Clive, Columbia, Commack, Coral Gables, Council Bluffs, Creve Coeur, Danville, Dayton, Decatur, Deerfield Beach, DeKalb, Des Moines, Detroit, Eau Claire, Effingham, Erie, Fargo, Farmington Hills, Farrell, Franklin, Gainesville, Geneva, Glen Burnie, Great Falls, Green Bay, Greensboro, Greenville, Harrison, Indiana, Irvine, Jackson, Kalispell, Kansas City, Kettering, La Jolla, Lake Forest, Lawton, Lee's Summit, Lewisburg, Lexington, Little Rock, Los Angeles, Louisville, Mattoon, Maywood, Menomonee Falls, Miami, Middletown, Milwaukee, Missoula, Montvale, Nashville, Newberg, New Castle, New Haven, New York, North Kansas City, Oak Creek, O'Fallon, Oklahoma City, Omaha, Ontario, Orange, Overland Park, Philadelphia, Pittsburgh, Plantation, Portland, Reidsville, Rhinelander, Richmond, Rochester, Roseville, Salt Lake City, San Diego, Savannah, Sioux Falls, Springfield, Stevens Point, St Louis, Stony Brook, Sturgeon Bay, Tampa, The Bronx, Troy, Trumbull, Uniondale, Urbana, Warrenville, Washington D.C., Waterford, Waukee, Wausau, Webster, Wesley Chapel, West Bend, West Des Moines, Westwood, Wilkes-Barre, Wisconsin Rapids, Yankton, York
- Age
- 18 years to 79 years
- People
- 188
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04671667 - Phase 3Taking peoplePalbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- Where
- Fargo, Kansas City, Sioux Falls, St Louis, Worthington
- Age
- 18 years and over
- People
- 81
- Run by
- Washington University School of Medicine
See details and how to joinNCT04966481 - Phase 2Taking peopleBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Where
- ‘Aiea, Albuquerque, Alexandria, Ames, Anaconda, Ankeny, Ann Arbor, Ashland, Aurora, Battle Creek, Bellevue, Bemidji, Bend, Beverly Hills, Billings, Bismarck, Bloomington, Boise, Boone, Boston, Bozeman, Brainerd, Brighton, Burnsville, Caldwell, Canton, Cape Girardeau, Carthage, Cedar Rapids, Centerville, Centralia, Chaska, Chelsea, Chicago, City of Saint Peters, Clackamas, Clinton, Clive, Coeur d'Alene, Colorado Springs, Coon Rapids, Creve Coeur, Danville, Dayton, Decatur, Deer River, DeKalb, Des Moines, Detroit, Detroit Lakes, Dixon, Duluth, Eau Claire, Edina, Effingham, Escanaba, Eureka, Fairfax, Falls Church, Fargo, Farmington Hills, Flint, Fort Collins, Fort Dodge, Fosston, Franklin, Fridley, Fruitland, Galesburg, Geneva, Glenview, Goldsboro, Grand Rapids, Grayslake, Great Falls, Greeley, Green Bay, Greenville, Hibbing, Honolulu, Irvine, Jacksonville, Jamestown, Jefferson, Kalamazoo, Kalispell, Kewanee, La Crosse, Lake Forest, Lake Success, Lansing, Lebanon, Little Rock, Livonia, Los Angeles, Loveland, Lynchburg, Macomb, Maplewood, Marshalltown, Marshfield, Mattoon, Maywood, Meridian, Milwaukee, Mineola, Minneapolis, Minocqua, Missoula, Mukwonago, Muskegon, Nampa, Newark, Newberg, New Richmond, New York, Niles, Normal, Norton Shores, Oconomowoc, Oconto Falls, O'Fallon, Oklahoma City, Omaha, Ontario, Orange, Oregon City, Orlando, Orland Park, Ottawa, Park Rapids, Pekin, Peoria, Peru, Philadelphia, Phoenix, Pontiac, Portland, Post Falls, Princeton, Rapid City, Reed City, Rice Lake, Richmond, Rochester, Saint Johnsbury, Saint Joseph, Saint Louis Park, Saint Paul, Salt Lake City, Sandpoint, Sandstone, Sheboygan, Shiloh, Sioux Falls, Springfield, Stevens Point, St Louis, Stoneham, Sturgeon Bay, Superior, Tappahannock, Traverse City, Troy, Twin Falls, Urbana, Virginia, Waconia, Warrenville, Washington, Waukee, Waukesha, Weston, Willow Grove, Woodbury, Wyoming, Yorkville, Ypsilanti
- Age
- 18 years and over
- People
- 150
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05136196 - Phase 1Taking peopleTesting the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
- Where
- Baltimore, Charlotte, Charlottesville, Chicago, Cincinnati, Concord, Fairway, Kansas City, Lexington, Newark, New Brunswick, Richmond, Tampa, The Bronx, West Chester, Westwood
- Age
- 18 years and over
- People
- 46 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05172245 - Phase 3Taking peopleTesting the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- Where
- Allentown, Ames, Anaconda, Ann Arbor, Aventura, Baltimore, Barrington, Basking Ridge, Bemidji, Bethlehem, Billings, Bismarck, Boise, Boone, Boston, Bozeman, Brighton, Burlington, Burnsville, Caldwell, Canton, Cape Girardeau, Carlisle, Cedar Rapids, Centerville, Chapel Hill, Charleston, Chelsea, Cherry Hill, Chicago, City of Saint Peters, Coeur d'Alene, Colorado Springs, Commack, Coon Rapids, Creve Coeur, Crown Point, Crystal Lake, Cudahy, Danville, Dayton, Decatur, Downers Grove, East Stroudsburg, Eau Claire, Edina, Effingham, Elgin, Erie, Fargo, Flint, Fort Collins, Fort Dodge, Franklin, Germantown, Glens Falls, Golden, Grafton, Great Falls, Greeley, Green Bay, Greensburg, Greenville, Harrisburg, Harrison, Hays, Hazel Crest, Hendersonville, Indiana, Jefferson, Johnstown, Kalispell, Kansas City, Kenosha, La Crosse, Lansing, Lawrence, Lawton, Lebanon, Lee's Summit, Liberty, Libertyville, Little Rock, Livonia, Loveland, Macomb, Maplewood, Marinette, Marshalltown, Marshfield, Marysville, Mattoon, Mechanicsburg, Miami Beach, Middletown, Milwaukee, Minneapolis, Missoula, Mitchell, Monroeville, Montvale, Mukwonago, Nampa, New Lenox, New York, Normal, Oak Lawn, Oconomowoc, O'Fallon, Oklahoma City, Olathe, Ontario, Oregon City, Orland Park, Osage Beach, Oshkosh, Overland Park, Palo Alto, Palos Heights, Park Ridge, Peoria, Philadelphia, Pierre, Pinehurst, Pittsburgh, Pontiac, Portland, Post Falls, Racine, Rice Lake, Richmond, Rockford, Saint Johnsbury, Saint Louis Park, Saint Paul, Salina, Sandpoint, Seneca, Sewell, Sheboygan, Shiloh, Sioux Falls, Springfield, Stevens Point, St Louis, Summit, Sylvania, Syracuse, Topeka, Troy, Two Rivers, Uniondale, Uniontown, Urbana, Verona, Washington, Waukesha, Wauwatosa, West Allis, Weston, Westwood, Yankton, Ypsilanti
- Age
- 18 years and over
- People
- 158
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06589804 - Phase 2Taking peopleAntibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
- Where
- Cleveland
- Age
- 18 years and over
- People
- 30
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06627270 - Early phase 1Taking peopleWindow Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)
- Where
- Nashville
- Age
- 18 years and over
- People
- 18
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT07741565 - Phase 2Not yet taking people in United StatesCirculating Tumor DNA-Informed Adjuvant Therapy for Intermediate-Risk Head and Neck Cancer
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 140
- Run by
- Kevin Contrera
See details and how to joinNCT07932067 - No phaseTaking peopleSelf-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
- Where
- Nashville, Philadelphia
- Age
- 18 years and over
- People
- 204
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT06125743 - Phase 1/2Taking peopleA Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
- Where
- Orlando, Tampa, Tulsa
- Age
- 18 years and over
- People
- 72
- Run by
- Theravectys S.A.
See details and how to joinNCT06319963 - No phaseTaking peopleVirtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and Caregivers
- Where
- Duarte
- Age
- 18 years and over
- People
- 40
- Run by
- City of Hope Medical Center
See details and how to joinNCT06985784 - Phase 1Taking peopleA Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Where
- Austin, Celebration, Denver, Detroit, Duarte, East Brunswick, Fairfax, Fort Worth, Houston, Irvine, Irving, Lake Success, Nashville, New Haven, New York, Plantation, San Antonio, Sarasota, Spokane, West Valley City
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07503808 · EU 2026-526299-21-00 - Phase 2Taking peopleBevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Thyroidectomy Patients
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 40
- Run by
- Matthew Spector
See details and how to joinNCT07631650 - No phaseNot yet taking people in United StatesMyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
- Where
- Detroit
- Age
- 18 years to 70 years
- People
- 100
- Run by
- Barbara Ann Karmanos Cancer Institute
See details and how to joinNCT07928154 - Phase 2Taking peopleIndocyanine Green With Near Infrared Imaging for Intraoperative Visualization of Head and Neck Squamous Cell Carcinoma
- Where
- St Louis
- Age
- 18 years and over
- People
- 25
- Run by
- Washington University School of Medicine
See details and how to joinNCT07825597 - Phase 2Not yet taking people in United StatesInduction Chemoimmunotherapy to Prevent Laryngectomy in Advanced Laryngeal Cancer and Hypopharyngeal Cancer
- Where
- Rochester
- Age
- 18 years and over
- People
- 50
- Run by
- Mayo Clinic
See details and how to joinNCT07923877 - No phaseNot yet taking people in United StatesRemoving the Planning Tumor Volume From Radiation Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma
- Where
- Duarte
- Age
- 18 years and over
- People
- 30
- Run by
- City of Hope Medical Center
See details and how to joinNCT07926906 - Phase 1/2Taking peopleStudy of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Where
- Allentown, Atlanta, Billings, Camden, Chicago, Clermont, Cleveland, Dallas, Detroit, Duarte, El Paso, Fairfax, Glendale, Grand Island, Grand Rapids, Iowa City, Knoxville, La Jolla, Lakewood, Los Angeles, Louisville, Milwaukee, Murrieta, Nashville, Omaha, Orange City, Portland, Saint Louis Park, Saint Paul, San Antonio, Santa Rosa, St Louis, The Bronx, The Woodlands, Tyler
- Age
- 18 years and over
- People
- 340 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT04198766 - No phaseTaking peopleA Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years to 89 years
- People
- 185
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05207098 - Phase 2Taking peopleA Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
- Where
- Baltimore, Columbia, Glen Burnie
- Age
- 18 years and over
- People
- 132
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT07418034 - Phase 2Taking peopleProton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial
- Where
- Rochester
- Age
- 18 years and over
- People
- 30
- Run by
- Mayo Clinic
See details and how to joinNCT07783581 - Phase 1Taking peopleAutologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 33
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06096038 - Phase 1Taking peopleA Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Where
- Boston, Conroe, Duarte, Houston, Irvine, League City, Los Angeles, Nashville, New Haven, Newton, San Antonio, Santa Monica, Sugar Land, Trumbull
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Pfizer
See details and how to joinNCT07090499 · EU 2025-521729-33-00 - No phaseNot yet taking people in United StatesGut-Liver-Muscle Axis in Cancer Cachexia
- Where
- Aurora
- Age
- 40 years to 89 years
- People
- 20
- Run by
- University of Colorado, Denver
See details and how to joinNCT07911150 - Phase 1/2Taking peopleVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Where
- Albuquerque, Englewood, Florham Park, Fort Lauderdale, Hartford, Houston, Morristown, New York, Pembroke Pines, Santa Rosa, Washington D.C., York
- Age
- 18 years to 80 years
- People
- 242 worldwide
- Run by
- VM Oncology, LLC
See details and how to joinNCT03556228